Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 2

The corrected QT interval prolongation in adolescents with cardiac iron overload β-thalassemia major

Pages
267–273
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

QTc interval of 449 ms could be considered as a cut-off point of cardiac iron overload.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and objectives.
📊
Key Findings & Data:The T2* magnetic resonance imaging (MRI) technique is the gold standard for iron load detection, yet it is expensive and not widely available especially in the developing countries.
💡
Conclusion & Impact:QTc interval of 449 ms could be considered as a cut-off point of cardiac iron overload.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background and objectives. Iron-induced cardiomyopathy remains the leading cause of mortality in β-thalassemia major patients. The T2* magnetic resonance imaging (MRI) technique is the gold standard for iron load detection, yet it is expensive and not widely available especially in the developing countries. Some previous studies showed that QTc interval could be used as an early detection of cardiac iron overload. This study aimed to evaluate the diagnostic value of QTc interval as a marker of early detection of cardiac iron overload in adolescent beta thalassemia major patients. Methods. We prospectively evaluated electrocardiography (ECG) parameter of QTc interval in 50 β-thalassemia major patients aged 10-18 years. All participants had a 12-lead ECG evaluation, echocardiogram and cardiac MRI T2* examination within three months (average 15 days). They were categorized as cardiac iron overload (MRI T2* 20 millisecond). Results. Of the 50 patients, the male to female ratio was 1.08:1 and the mean age was 13.7 ± 2.43 years. All participants showed normal systolic and diastolic function using conventional echocardiography. The mean QTc interval was significantly different between cardiac iron overload group (464.44 ± 20.35 ms) and noncardiac iron overload group (431.09 ± 32.29) (p= 0.001). Diagnostic study of QTc interval resulted in AUC 0.8 (p= 0.002). Calculated sensitivity and specificity of QTc interval were 0.88 and 0.73 respectively, with cut-off point of 449 ms. Conclusion. Cardiac iron overload is associated with QTc prolongation in adolescents. QTc interval of 449 ms could be considered as a cut-off point of cardiac iron overload.

🔖

Cite This Article

ADVANI, N., KAUTSAR, A., ANDRIASTUTI, M. (2020). The corrected QT interval prolongation in adolescents with cardiac iron overload β-thalassemia major. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 2, 267–273. https://ajindex.com/articles/411926

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480- 487
  2. Hershko C. Iron loading and its clinical implication. Am J Hematol 2007; 82(Suppl 12): 1147-1148
  3. Martin A, Thompson AA. Thalassemias. Pediatr Clin N Am 2013; 60: 1383-1391
  4. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in beta-thalassemia major. A cause of heart failure. Circulation 1995; 91: 66-71
  5. Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG. Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation 1999; 100: 2074-2078
  6. Economou-Petersen E, Aessopos A, Kladi A, et al. Apolipoprotein E epsilon-4 alelle as a genetic risk factor for left ventricular failure in homozygous thalassemia. Blood 1998; 92: 3455-3459
  7. Modell B, Khan M, Darlison M. Survival in beta thalassemia major in the UK: data from the UK Thalassemia register. Lancet 2000; 355: 2051-2052
  8. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Hematologica 2004; 89: 1187-1193
  9. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084
  10. Tanner MA, Galanello R, Dessi C, et al. A randomized, placebo-cotrolled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007; 115: 1876-1884
  11. Farmaki K, Tzoumari I, Pappa C, Chouliaras G, Berdoukas V. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complication of thalassemia major. Br J Haematol 2010; 148: 466-475
  12. Porter JB. Optimizing iron chelation strategies in beta-thalassemia major. Blood Rev 2009; 23(Suppl 1): S3-S7
  13. Davis BA, O’Sullivan C, Jarrit PH, Porter JB. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 2004; 104: 263-269
  14. Wood JC, Enriquez C, Ghugre N, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci 2005; 1054: 386-395
  15. De Chiara B, Crivellaro W, Sara R, et al. Early detection of cardiac dysfunction in thalassem